|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12Q 1/68 | |
| G01N 33/574 |
| (11) | Patento numeris | 3234193 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15832934.2 |
| Europos patento paraiškos padavimo data | 2015-12-21 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-10-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-07-15 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/067143 |
| Data | 2015-12-21 |
| (87) | Numeris | WO 2016/100975 |
| Data | 2016-06-23 |
| (30) | Numeris | Data | Šalis |
| 201462124473 P | 2014-12-19 | US |
| (72) |
HACOHEN, Nir, US
ROONERY, Michael, S., US
|
| (73) |
The General Hospital Corporation,
55 Fruit Street, Boston, MA 02114,
US
Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02142, US |
| (54) | MOLECULAR BIOMARKERS FOR CANCER IMMUNOTHERAPY |
| MOLECULAR BIOMARKERS FOR CANCER IMMUNOTHERAPY |